Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-21-005473
Filing Date
2021-05-03
Accepted
2021-05-03 08:30:28
Documents
58
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q glyc-20210331x10q.htm   iXBRL 10-Q 980464
2 EX-31.1 glyc-20210331xex31d1.htm EX-31.1 17027
3 EX-31.2 glyc-20210331xex31d2.htm EX-31.2 16849
4 EX-32.1 glyc-20210331xex32d1.htm EX-32.1 9456
  Complete submission text file 0001558370-21-005473.txt   4635766

Data Files

Seq Description Document Type Size
5 EX-101.SCH glyc-20210331.xsd EX-101.SCH 31332
6 EX-101.CAL glyc-20210331_cal.xml EX-101.CAL 37130
7 EX-101.DEF glyc-20210331_def.xml EX-101.DEF 147131
8 EX-101.LAB glyc-20210331_lab.xml EX-101.LAB 290794
9 EX-101.PRE glyc-20210331_pre.xml EX-101.PRE 275383
10 EXTRACTED XBRL INSTANCE DOCUMENT glyc-20210331x10q_htm.xml XML 787793
Mailing Address 9708 MEDICAL CENTER DRIVE ROCKVILLE MD 20850
Business Address 9708 MEDICAL CENTER DRIVE ROCKVILLE MD 20850 240-243-1201
GLYCOMIMETICS INC (Filer) CIK: 0001253689 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36177 | Film No.: 21881513
SIC: 2834 Pharmaceutical Preparations